Authors
Loading...
Research reveals T cell-based therapies may enhance immunity by targeting apoptotic signals and tumor microenvironment factors.
Bennion et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: